Prevalence and associated factors of multi-drug resistant bacteria among different clinical specimens at wad Medani, Sudan: a four-year, cross-sectional study
Abstract Multi-drug resistant organisms (MDROs) are a global health concern. Therefore, the aim of the study is to evaluate the prevalence of MDROs and associated factors among different clinical specimens. This was a retrospective cross-sectional study, conducted between January 2020 to October 202...
Saved in:
| Main Authors: | Yousif B. Hamadalneel, Safa F. Eltoum, Zainab M. Almustafa, Wageeda S. Mustafa, Fatima O. Abdelsalam, Yousif M. Yousif, Asgad A. Alsdeeg, Marwa F. Alamin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-00714-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence, antimicrobial resistance patterns, and associated factors of Staphylococcus aureus among different clinical specimens in Wad Medani, Sudan: a four-year, laboratory-based, retrospective study
by: Yousif B. Hamadalneel, et al.
Published: (2025-07-01) -
Correction: Prevalence, antimicrobial resistance patterns, and associated factors of Staphylococcus aureus among different clinical specimens in Wad Medani, Sudan: a four-year, laboratory-based, retrospective study
by: Yousif B. Hamadalneel, et al.
Published: (2025-08-01) -
Bacterial Profile, Antimicrobial Susceptibility Patterns, and Associated Factors in Wound Infection Patients at Wad Medani, Sudan: A Four-year, Laboratory-based, Retrospective, Cross-sectional Study
by: Yousif B. Hamadalneel, et al.
Published: (2025-06-01) -
Knowledge of pharmacists about anti-epileptic drugs in Sudan: a cross-sectional analytical study
by: Fatima O. Abdelsalam, et al.
Published: (2025-05-01) -
Insights into stress ulcer prophylaxis among non-critically ill patients: a tertiary hospital perspective from Sudan
by: Maram M. Elamin, et al.
Published: (2025-08-01)